Author

Xiang Liu

Institutions: Hua Medicine (China), Jiangsu College of Nursing

Observed institutions: Hua Medicine (China), Jiangsu College of Nursing

ORCID: 0000-0002-8217-0577

Observed ORCID: 0000-0002-8217-0577

OpenAlex ID: A5134167848

A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity

2023 · Li Chen, Jiayi Zhang, et al. · Nature Communications · 27

A pharmacokinetic and pharmacodynamic drug-drug interaction study of dorzagliatin and empagliflozin in patients with type 2 diabetes and obesity: an open-label phase I trial

2026 · Huan Liu, Yuanhui Zhang, et al. · Nature Communications

The effectiveness and safety of oral anticoagulation therapy in patients undergoing transcatheter aortic valve replacement: a systematic review/meta-analysis

2026 · Qiang Zhou, Xiang Liu, et al. · European Journal of Clinical Pharmacology

HoloSR-Diff: A dual-path diffusion framework for high-fidelity holographic super-resolution

2026 · Xirun Cheng, Yong Liu, et al. · SSRN Electronic Journal

Hyaluronic acid-inulin conjugate-mediated ternary nanoparticles: Interfacial stabilization of Pickering emulsions and enhanced delivery of ɑ-linolenic acid

2026 · Guangqi Guo, Zhenxia Xu, et al. · SSRN Electronic Journal

Works count: 5

Citation count: 27

H-index: 1

I10-index: 1